AstraZeneca’s diabetes drug Farxiga could face generic competition in the US, after the FDA gave tentative approval to a generic rival from India’s Glenmark, although it is unclear when the ...

Jardiance is only available under its brand name. On the other hand, dapagliflozin, the active ingredient in Farxiga, is ...

cholesterol pill fall away because of generic competition. Sales of Farxiga were up 57% to $239 million in Q4 2016, compared with the same period in 2015, and the company hopes the data will help ...